Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens
- 1 April 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (4) , 687-690
- https://doi.org/10.1016/s0959-8049(96)00491-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: Clinical evidence of incomplete cross-resistanceAnnals of Oncology, 1994
- Synergism and Lack of Cross-resistance Between Short-term and Continuous Exposure to Fluorouracil in Human Colon Adenocarcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerEuropean Journal Of Cancer, 1993
- Chemotherapy for metastatic colorectal cancerCancer, 1992
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Doxifluridine in advanced colorectal cancerJournal of Surgical Oncology, 1991
- Doxifluridine (5?-dFUrd) in patients with advanced colorectal carcinomaCancer Chemotherapy and Pharmacology, 1985
- Phase II study of doxifluridine in advanced colorectal adenocarcinoma.Journal of Clinical Oncology, 1983
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridinePublished by Elsevier ,1980
- Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosidesJournal of Medicinal Chemistry, 1979